Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer.
New research highlights the importance of combining clinical, pathological, and radiological data for better NSCLC immunotherapy outcomes. 📊💉
